Search

everythinglearnresearchcommunity

for

Search:↓

Cancer patients treated with immune checkpoint inhibitors may develop alopecia, but some hair regrowth is possible with treatment.

Genetics and hormones play a role in male and female hair loss, but more research is needed to fully understand it.

Oral dutasteride and topical pimecrolimus can safely and effectively treat Frontal Fibrosing Alopecia, leading to significant hair regrowth.

Oral dutasteride can potentially treat frontal fibrosing alopecia in postmenopausal women, with some patients showing disease arrest and hair regrowth.

A new type of rapid hair loss called ADTA usually gets better on its own within 6 months.

The cause of Frontal Fibrosing Alopecia is unclear, diagnosis involves clinical evaluation and various treatments exist, but their effectiveness is uncertain.

Docetaxel and paclitaxel for breast cancer can cause permanent, severe hair loss.

Environmental factors at different levels control hair stem cell activity, which could lead to new hair growth and alopecia treatments.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

The document concludes that post-menopausal frontal fibrosing alopecia is a poorly understood condition that does not respond well to common treatments.

Targeted cancer therapies have a significant but lower risk of causing hair loss compared to chemotherapy.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Alopecia Areata is a complex, unpredictable autoimmune hair loss condition with limited treatment options and a significant psychological impact.

Most dogs with alopecia had higher than normal levels of certain hormones, but hair loss might not always be linked to these hormone changes.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Treatments for Frontal Fibrosing Alopecia have not been proven effective.

The exact cause of growth hormone-responsive alopecia in dogs is unclear.

Early diagnosis and aggressive treatment are key for managing rare scalp disorders that cause permanent hair loss.

The document concludes that there are no reliable treatments for frontal fibrosing alopecia, with only temporary benefits from current options.

Parathyroid hormones are important for hair growth, but their use in treating hair loss from chemotherapy is still uncertain.

Some patients with a type of skin lymphoma can experience a rare, non-scarring hair loss that looks like another hair loss condition but has distinct features.

Experts agreed on guidelines to improve research on Frontal Fibrosing Alopecia.

Hodgkin's lymphoma can show up as hair loss.

Patients with severe alopecia areata have higher levels of MIF, which decrease after successful treatment.

Some women with Frontal Fibrosing Alopecia also have Lichen Planopilaris, which can lead to more symptoms and affect hair outside the scalp.

A mother and daughter with similar hair loss conditions and identical HLA types suggest a genetic link between the conditions.

Some treatments can help hair regrowth in alopecia areata, but none offer a cure, and effectiveness varies.

Dupilumab may worsen Alopecia Areata in some males but improve it in some females, suggesting personalized treatment is needed.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.